Company intelligence / Profile preview

Applied Therapeutics, Inc.

New York, New York, United Statesappliedtherapeutics.com ↗
Ownership
Public · APLT
Employees
~35
Development stage
Other
01

Overview

Applied Therapeutics has completed Phase 3 trials for govorestat (AT-007) in galactosemia and received a Complete Response Letter from the FDA in November 2024. The company reported positive 12-month interim results from the Phase 3 INSPIRE trial for SORD Deficiency in February 2024, with primary endpoints and several key secondary endpoints achieved. Their AT-001 compound for Diabetic Cardiomyopathy has completed Phase 3 trials.

Therapeutic areas
CardiovascularMetabolic DisordersOphthalmologyEndocrinologyRare DiseasesNeurology
Modalities
Small molecules (Aldose Reductase Inhibitors)
Industry
Biotech
02

Drug pipeline

5 assets

caficrestat

3

4 more assets in the full pipeline.

03

Partnerships

Advanz Pharma (commercialization of AT-007/govorestat in Europe)Mercury Pharma Group Limited (exclusive license and supply agreement for drug products containing AT-007)

Beyond the preview

Go deeper on Applied Therapeutics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Applied Therapeutics, Inc..

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call